Abstract
Even after many discoveries and inventions of new nanomaterial devices for biomedical applications, still there were no stringent rules and regulations framed for the pharmaceutical products or the biomedicines developed from it. As a result, there was a bridge gap between biomedical advancement and clinical trials. This chapter discusses about the nanomaterial’s advancement, importance and its key role in the development of novel and improvised biomedical devices for many health-related issues in human body. There was a sharp edge of advancement with many novel inventions, at the same time there was a lack in discipline in the ethical issues and advancement related to it. Hence this chapter clearly connects the bridge between the issues and presented some improvisations for the development of nanobiomedical devices and their ethical issues.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Arts JHE, Hadi M, Irfan M, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, Wiench K, Wohlleben W, Landsiedel R, Warheit D (2015) A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul Toxicol Pharm 71:S1–S27
ASTM E2524 – 08 (2013) Standard test method for analysis of hemolytic properties of nanoparticles. https://www.astm.org/Standards/E2524.htm
ASTM E2865 – 12 (2018) Standard guide for measurement of electrophoretic mobility and zeta potential of nanosized biological materials. https://www.astm.org/Standards/E2865.htm
ASTM E3143 – 18b. Standard practice for performing cryo-transmission electron microscopy of liposomes. https://www.astm.org/Standards/E3143.htm
ASTM WK54872. New test method for measuring the size of nanoparticles in aqueous media using dynamic light scattering. https://www.astm.org/DATABASE.CART/WORKITEMS/WK54872.htm
Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR (2016) Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date. Pharm Res. 33(10):2373–2387
Caster JM, Patel AN, Zhang T, Wang A (2017) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(1). https://doi.org/10.1002/wnan.1416
Centerwatch (2017) FDA approved drugs. Accessed 25 Oct 2017. https://www.centerwatch.com/directories/1067-fda-approved-drugs
Clichici S and Filip A (2015) Nanomaterials—toxicity and risk assessment. In In vivo assessment of nanomaterials toxicity. Licensee InTech.
Food and Drug Administration (2017) Novel drug approvals for 2017. Oct 20.
Jones C, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev. 61(6):438–456
Kuzma J, Priest S (2010) Nanotechnology, risk and oversight: learning lessons from related emerging technologies. Risk Anal 30(11):1688–1698
OECD (1984) Test no. 207. OECD guideline for the testing of chemicals – OECD.org. http://www.biotecnologiebt.it/en/oecd-207-earthworm-acute-toxicity-test.php
OECD (2004a) Test no. 222. OECD guidelines for the testing of chemicals – OECD iLibrary. https://www.oecd-ilibrary.org/docserver/9789264090934-en.pdf?expires=1590049974&id=id&accname=guest&checksum=4673559129D22EA66999129493D5AF47
OECD (2004b) Test no. 209. OECD principles of corporate governance – 2004b Edition. http://www.oecd.org/corporate/ca/corporategovernanceprinciples/31557724.pdf
OECD (2013) Test no. 246. OECD guidelines for the testing of chemicals, section 2. Test no. 236: fish embryo acute toxicity (FET) test. https://www.oecdilibrary.org/environment/test-no-236-fish-embryo-acute-toxicity-fet-test_9789264203709-en
OECD (2010) Test no. 207. Earthworm, acute toxicity tests” A. Introduction, purpose. www.oecd.org/chemicalsafety/risk-assessment/1948293.pdf
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Santhini, O.E., Kirupha, S.D. (2020). Nanomaterials and Ethical Issues. In: Khan, F. (eds) Applications of Nanomaterials in Human Health. Springer, Singapore. https://doi.org/10.1007/978-981-15-4802-4_14
Download citation
DOI: https://doi.org/10.1007/978-981-15-4802-4_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4801-7
Online ISBN: 978-981-15-4802-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)